top of page
OUR PIPELINE
Lario Therapeutics are targeting severe developmental and epileptic encephalopathies and neurodegenerative disorders.
HIT ID
LEAD GENERATION
LEAD OPTIMIZATION
IND ENABLING STUDIES
INDICATIONS
Genetic Epilepsies,
DEE69, CDKL5
Parkinson’s Disease, PTSD
CaV2.3 Modulators
HIT ID
LEAD GENERATION
LEAD OPTIMIZATION
IND ENABLING STUDIES
INDICATIONS
Genetic Hemiplegic Migraine, Neurodevelopmental Disorders
CaV2.1 Modulators
HIT ID
LEAD GENERATION
LEAD OPTIMIZATION
IND ENABLING STUDIES
INDICATIONS
Parkinson’s Disease, Treatment Resistant Hypertension, Autism-Related Syndromes
CaV1.3 Modulators
bottom of page